Loading
₹3,570.00
−3.40−0.10%today
Market closed · 7 Oct, 3:30 pm
+45.16%over 1 year
Today's range
₹3,529.30₹3,611.00
52-week range
₹2,380.20₹3,796.00
Revenue and net profit in ₹ crore, consolidated where the company reports both.
| Year | Revenue | Net profit | Margin | EPS (₹) |
|---|---|---|---|---|
| FY26 | 5,407 | 1,056 | 19.5% | 84.51 |
| FY25 | 4,588 | 920 | 20.1% | 73.53 |
| FY24 | 4,162 | 816 | 19.6% | 64.77 |
| FY23 | 3,708 | 588 | 15.9% | 45.89 |
As of Jun 2026, as a share of all the company's shares.
| Holder | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 |
|---|---|---|---|---|
| Promoters | 63.48% | 66.25% | 66.25% | 66.25% |
| FIIs | 7.68% | 8.26% | 7.98% | 8.53% |
| DIIs | 21.80% | 18.37% | 18.58% | 17.90% |
| of which mutual funds | 18.10% | 15.22% | 15.49% | 14.67% |
| Government | n/a | 0.01% | 0.01% | 0.01% |
| Public | 7.03% | 7.12% | 7.19% | 7.32% |
From the company's quarterly filings with NSE. FIIs are foreign institutions; DIIs are Indian ones such as mutual funds, insurers and banks.
Healthcare companies in the Nifty 500 closest in size.
| Company | Price (₹) | Change | Market cap (₹ cr) |
|---|---|---|---|
| Abbott India Ltd.ABBOTINDIA | 26,100.00 | −0.06% | 55,461 |
| Gland Pharma Ltd.GLAND | 3,159.00 | +5.09% | 52,127 |
| Anthem Biosciences Ltd.ANTHEM | 887.05 | −0.37% | 49,988 |
| Ipca Laboratories Ltd.IPCALAB | 1,929.00 | −0.85% | 48,940 |
| Ajanta Pharmaceuticals Ltd.AJANTPHARM · this stock | 3,570.00 | −0.10% | 44,610 |
| Glaxosmithkline Pharmaceuticals Ltd.GLAXO | 2,628.00 | −4.61% | 44,520 |
| Emcure Pharmaceuticals Ltd.EMCURE | 1,920.00 | −0.12% | 36,424 |
Price and volume from NSE; key figures and results from Yahoo Finance; shareholding and corporate actions from the company's NSE filings. Figures can run behind the exchange. For information only, not a recommendation to invest.